Search research articles
Contact Us
Filters
Showing results (161-170 of 223) with videos related to
Page
of 23
Sort By:
Journal of the American College of Cardiology
|
May 7, 2021
Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals
Vibhu Parcha, Nirav Patel, Orlando M Gutierrez, et al.
Circulation. Genomic and Precision Medicine
|
January 28, 2022
Genetic European Ancestry and Incident Diabetes in Black Individuals: Insights From the SPRINT Trial
Vibhu Parcha, Brittain Heindl, Rajat Kalra, et al.
JCI Insight
|
June 5, 2019
Racial differences in the association of NT-proBNP with risk of incident heart failure in REGARDS
Nirav Patel, Mary Cushman, Orlando M Gutiérrez, et al.
Circulation. Genomic and Precision Medicine
|
May 28, 2025
Association of Pathogenic/Likely Pathogenic Genetic Variants for Cardiomyopathies With Clinical Outcomes: A Multiancestry Analysis in the All of Us Research Program
Naman S Shetty, Akhil Pampana, Mokshad Gaonkar, et al.
JAMA Cardiology
|
November 13, 2020
Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Trial (SPRINT)
Shreya Rao, Matthew W Segar, Adam P Bress, et al.
JAMA
|
April 4, 2022
Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals
Vibhu Parcha, Gargya Malla, Marguerite R Irvin, et al.
Nature Communications
|
February 13, 2025
Differences in natriuretic peptide response in self-identified white and black individuals: a physiological clinical trial
Naman S Shetty, Mokshad Gaonkar, Nirav Patel, et al.
JAMA Cardiology
|
September 30, 2024
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF Trial
Sanjiv J Shah, Marzia Rigolli, Atefeh Javidialsaadi, et al.
JAMA Cardiology
|
October 23, 2024
Utility of a Systolic Blood Pressure Polygenic Risk Score With Chlorthalidone Response
Nicole D Armstrong, Vinodh Srinivasasainagendra, Amit Patki, et al.
Mayo Clinic Proceedings
|
April 12, 2021
Relative Predictive Value of Circulating Immune Markers in US Adults Without Cardiovascular Disease: Implications for Risk Reclassification
Kartik Gupta, Rajat Kalra, Mike Pate, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 223) with videos related to
Sort By:
Page
of 23
Journal of the American College of Cardiology
|
May 7, 2021
Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals
Vibhu Parcha, Nirav Patel, Orlando M Gutierrez, et al.
Circulation. Genomic and Precision Medicine
|
January 28, 2022
Genetic European Ancestry and Incident Diabetes in Black Individuals: Insights From the SPRINT Trial
Vibhu Parcha, Brittain Heindl, Rajat Kalra, et al.
JCI Insight
|
June 5, 2019
Racial differences in the association of NT-proBNP with risk of incident heart failure in REGARDS
Nirav Patel, Mary Cushman, Orlando M Gutiérrez, et al.
Circulation. Genomic and Precision Medicine
|
May 28, 2025
Association of Pathogenic/Likely Pathogenic Genetic Variants for Cardiomyopathies With Clinical Outcomes: A Multiancestry Analysis in the All of Us Research Program
Naman S Shetty, Akhil Pampana, Mokshad Gaonkar, et al.
JAMA Cardiology
|
November 13, 2020
Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Trial (SPRINT)
Shreya Rao, Matthew W Segar, Adam P Bress, et al.
JAMA
|
April 4, 2022
Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals
Vibhu Parcha, Gargya Malla, Marguerite R Irvin, et al.
Nature Communications
|
February 13, 2025
Differences in natriuretic peptide response in self-identified white and black individuals: a physiological clinical trial
Naman S Shetty, Mokshad Gaonkar, Nirav Patel, et al.
JAMA Cardiology
|
September 30, 2024
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF Trial
Sanjiv J Shah, Marzia Rigolli, Atefeh Javidialsaadi, et al.
JAMA Cardiology
|
October 23, 2024
Utility of a Systolic Blood Pressure Polygenic Risk Score With Chlorthalidone Response
Nicole D Armstrong, Vinodh Srinivasasainagendra, Amit Patki, et al.
Mayo Clinic Proceedings
|
April 12, 2021
Relative Predictive Value of Circulating Immune Markers in US Adults Without Cardiovascular Disease: Implications for Risk Reclassification
Kartik Gupta, Rajat Kalra, Mike Pate, et al.
Page
of 23